<DOC>
	<DOCNO>NCT00621764</DOCNO>
	<brief_summary>Safety : To describe safety profile follow vaccination . Immunogenicity : To describe immune response single dose vaccine .</brief_summary>
	<brief_title>Immunogenicity Safety ChimeriVaxâ„¢ Japanese Encephalitis Vaccine Thai Toddlers Children</brief_title>
	<detailed_description>This randomize , cross-over , open , active control , multi-center trial toddler child Thailand . Stepwise enrollment child 2 age cohort . Subjects follow 5 year .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Encephalitis , Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Provision consent form sign least one parent another legally acceptable representative , least one independent witness . Completion vaccination accord national immunization schedule Subject parent/legally acceptable representative able attend schedule visit comply trial procedure . Previous receipt two dos mousebrainderived JE vaccine 12 15 month age accord national immunization schedule age 2 5 year day inclusion . Aged 12 24 month day inclusion receive JE vaccine . Participation another clinical trial investigate vaccine , drug , medical device , medical procedure 4 week precede first trial vaccination . Known suspected congenital acquire immunodeficiency , immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 6 month , longterm systemic corticosteroid therapy . Known systemic hypersensitivity vaccine component history lifethreatening reaction trial vaccine vaccine contain substance . Chronic illness , stage could interfere trial conduct completion , opinion Investigator . Receipt blood bloodderived product past 3 month , might interfere assessment immune response . Receipt hepatitis A vaccine . History flavivirus infection ( confirm either clinically , serologically microbiologically ) . Administration antiviral within 2 month precede screen visit . History central nervous system disorder disease . Personal family history thymic pathology ( thymoma ) , thymectomy , myasthenia . Planned participation another clinical trial present trial period . Receipt vaccine 4 week precede first trial vaccination . Planned receipt vaccine 4 week follow trial vaccination . Personal human immunodeficiency virus , hepatitis B hepatitis C seropositivity blood sample take screening . Thrombocytopenia , bleed disorder anticoagulant 3 week precede inclusion contraindicate IM vaccination . Previous vaccination flavivirus disease time trial mousebrainderived JE vaccine give twodose regimen 12 15 month age accordance national immunization schedule . Febrile illness acute illness/infection day vaccination , accord investigator judgment History seizure . Previous vaccination flavivirus disease .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Japanese encephalitis ( JE )</keyword>
	<keyword>Hepatitis A</keyword>
	<keyword>Inactivated Mouse-Brain</keyword>
</DOC>